|
|
||||||||
|
|
|||||||||
|
|
Oncology-Clinical Diagnosis: Solid TumorsClinical Diagnosis-Solid Tumors Posters |
1 Radiology, Kinki Univ., Osaka, Japan
1544
Objectives: To investigate whether integrated FDG-PET/CT can differentiate benign from malignant adrenal lesions by maximum of Standardized Uptake Value (SUVmax) and Hounsfield Number (HN) of unenhanced CT.
Methods: We studied 30 patients with 35 adrenal lesions (16 adenomas: size 16±5mm, 15 pts and 19 metastases: 24±12mm, 15 pts), who had confirmed primary malignancies (lung cancer in 23 patients, lymphoma in 2, esophageal cancer in 2, hypopharyngeal cancer in 1 and prostate cancer in 1) and a cancer screening subject in 1. All patients underwent PET/CT at 1h post FDG injection. Diagnosis of metastasis was based on interval growth (unchanged >1year =adenoma) or reduction after chemotherapy. FDG uptake and CT attenuation were measured by placing regions of interest over PET/CT images. Adrenal uptake of SUVmax
2.5 and <2.5 was considered metastases and adenomas, respectively. Unenhanced CT obtained by PET/CT data was considered positive for metastases based on HN
10HU, while lesions with HN<10HU were considered adenomas. Mann-Whitney's U test was used for statistical analyses.
Results: Adrenal adenomas showed to accumulate FDG (2.1±0.5), although to a lesser degree, whereas metastases showed higher SUVmax (7.4±3.5, p<0.05). HN of adrenal adenomas (10.1±12.3HU) was lower than that of metastases (27.6±11.9HU, p<0.05). For the differentiation between adrenal adenomas and metastases, a CT threshold of 10 HU or less corresponded to a sensitivity of 56%, specificity of 95% and accuracy of 77%. And a cut-off value using SUVmax of 2.5 was 88% sensitive, 95% specific and 91% accurate. For the diagnosis of adenomas, 5 of 7 false-negative lesions by HN were correctly diagnosed by SUVmax.
Conclusions: The additional value of SUVmax allows higher accuracy for the diagnosis of adrenal lesions with cancer patients.
| ||||||||||||||||||||||||||||||||||||||